» Articles » PMID: 31190887

Mitochondria P-glycoprotein Confers Paclitaxel Resistance on Ovarian Cancer Cells

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2019 Jun 14
PMID 31190887
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Subcellular expression of P-glycoprotein (P-gp) may play an essential role in multidrug resistance (MDR) in many cancers. However, the mitochondria expression and functional activity of P-gp in ovarian cancer are still unclear. In this study, we isolated mitochondria from A2780 cell line and its paclitaxel-resistant subline A2780T and investigated the expression and function of mitochondria P-gp. Immunocytochemistry was used to evaluate P-gp expression and subcellular localization in cancer cells. Immunofluorescence and laser confocal microscopy were used to detect the co-localization of P-gp and mitochondria both in ovarian cancer tissues and in cell lines. Western blotting (WB), transmission electron microscopy and JC-1 kit were used to evaluate the purity, integrity and activity of the isolated mitochondria. P-gp expression in the whole cell and the isolated mitochondria was evaluated by WB. Flow cytometry was used to evaluate the efflux function of mitochondria P-gp. P-gp expression was detected at the membrane, cytoplasm and nuclei of the A2780T cells, but not in the A2780 cells. Co-localization of P-gp and mitochondria was observed in the A2780T cell line and ovarian cancer tissues, but not in A2780 cells. The purity, integration and activity of the isolated mitochondria are high. P-gp was highly expressed in the A2780T cells and the isolated mitochondria, but was not found in A2780 cells. Rho123 efflux rate was significantly increased in isolated A2780T mitochondria compared to those in A2780 (43.2% vs 9.6%), but it was partly reversed by cyclosporin A (CsA, a P-gp inhibitor). P-gp is highly expressed in mitochondria of taxol-resistant ovarian cancer cells and ovarian cancer tissues and mediates the drug efflux, which probably protect cancer cells from chemotherapy.

Citing Articles

Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022.

Cabarca S, Ili C, Vanegas C, Gil L, Vertel-Morrinson M, Brebi P Front Oncol. 2024; 14:1450675.

PMID: 39588300 PMC: 11586235. DOI: 10.3389/fonc.2024.1450675.


Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration.

Kose S, Gulec Taskiran A Biol Open. 2024; 13(10).

PMID: 39445740 PMC: 11554266. DOI: 10.1242/bio.060448.


Tephrosin Suppresses the Chemoresistance of Paclitaxel-Resistant Ovarian Cancer via Inhibition of FGFR1 Signaling Pathway.

Kim H, Bae S, Lim Y, So K, Kim T, Bae S Biomedicines. 2023; 11(12).

PMID: 38137377 PMC: 10740824. DOI: 10.3390/biomedicines11123155.


The Plasma Membrane Monoamine Transporter is Highly Expressed in Neuroblastoma and Functions as an mIBG Transporter.

Vieira L, Zhang Y, Quinones A, Hu T, Singh D, Stevens J J Pharmacol Exp Ther. 2023; 387(3):239-248.

PMID: 37541765 PMC: 10658915. DOI: 10.1124/jpet.123.001672.


Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics.

Hassan M, Romana B, Mao G, Kumar N, Sonvico F, Thordarson P Pharmaceutics. 2023; 15(7).

PMID: 37514072 PMC: 10385268. DOI: 10.3390/pharmaceutics15071886.


References
1.
Demeule M, Brossard M, Beliveau R . Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol. 1999; 277(6):F832-40. DOI: 10.1152/ajprenal.1999.277.6.F832. View

2.
Kaufmann S, Earnshaw W . Induction of apoptosis by cancer chemotherapy. Exp Cell Res. 2000; 256(1):42-9. DOI: 10.1006/excr.2000.4838. View

3.
Wang T, Wang H, Soong Y . Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer. 2000; 88(11):2619-28. DOI: 10.1002/1097-0142(20000601)88:11<2619::aid-cncr26>3.0.co;2-j. View

4.
Meschini S, Calcabrini A, Monti E, Del Bufalo D, Stringaro A, Dolfini E . Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells. Int J Cancer. 2000; 87(5):615-28. View

5.
Calcabrini A, Meschini S, Stringaro A, Cianfriglia M, Arancia G, Molinari A . Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells. Histochem J. 2001; 32(10):599-606. DOI: 10.1023/a:1026732405381. View